Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Flexion reports pharmacokinetic results for FX-006 in knee osteoarthritis

June 20, 2014

BMS-817399 fails to improve rheumatoid arthritis in phase II proof-of-concept study

June 19, 2014

Immunomodulator HMPL-523 enters first-in-human trial

June 19, 2014

Piramal Enterprises patents new proinflammatory cytokine inhibitors

June 19, 2014

NNC-0151-0000 development halted, second-generation compound shows improved profile

June 19, 2014

ABP-501 proves equivalent to adalimumab in healthy volunteers

June 19, 2014

Results from phase I trial of PF-06438179, a biosimilar to infliximab

June 19, 2014

Phase I results for the rituximab biosimilar PF-05280586

June 18, 2014

CKD-L, an HDAC6 inhibitor, may have potential for the treatment of RA

June 18, 2014

Rheumatoid arthritis candidate BI-638683 well tolerated in phase I study

June 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...